Facts & Figures
From an exciting yesterday into a promising tomorrow.
Baxter Vaccines, headquartered in Vienna/Austria, has more than 600 employees worldwide. We have two research facilities: Biomedical Research Center in Orth/Austria and Columbia/Maryland/USA. Currently we have two products on the European market: our TBE vaccine and a vaccine against group C meningococcal meningitis, the NeisVac-C vaccine.
Together with the BioPharmaceuticals and BioSurgery businesses we represent Baxter's BioScience division. Here in BioScience we offer products like life-saving recombinant Factor VIII for hemophilia patients, immune globulins to help people combat immune deficiencies, fibrin sealants and vaccines.
Baxter International Inc is a global medical products and services company with a mission of delivering critical therapies for people with life-threatening conditions through its three major businesses - BioScience, Medication Delivery and Renal. Our products and services are used to treat patients with many conditions. With 2000 sales of $6.9 billion, and more than 45,000 people around the world dedicated to one mission, Baxter is recognized as a global leader in developing innovative solutions that improve patients' quality of life.